drug-related problems (DRP)
Conditions
Interventions
Group 1: Intervention group: Admission to the emergency department with pharmaceutical and medical care
Group 2: Control group: Admission to the emergency department with standard medical care only
Sponsors
Apotheke der Universitätsmedizin Mainz
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • Patients of the internal medicine emergency department of the University Medical Center Mainz taking at least five long-term medications • Patients of the internal medicine emergency department of the University Medical Center Mainz for whom inpatient admission to a subsequent specialist department is expected • Age of 18 years or older • Patients who are able to read and understand German • Willingness to participate in the study: written informed consent for participation and data collection
Exclusion criteria
Exclusion criteria: • Patients of the internal medicine emergency department of the University Medical Center Mainz with acute life-threatening conditions, in particular acute strokes, heart attacks, drug-induced conditions, suicidal patients, or epileptic seizures • Lack of insight or ability to give informed consent • No willingness to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of the study was the number of unsolved and confirmed DRPs with high relevance, noted in IG patients after the collaborative AMTS-Check and noted in CG patients after the AMTS-Check performed by the emergency physician | — |
Secondary
| Measure | Time frame |
|---|---|
| The following additional research questions were investigated in this study: How does pharmaceutical care influence the length of hospital stay? What is the mean number of consented, unresolved drug-related problems (DRPs) of moderate and minor relevance in the intervention group (IG) compared to the control group (CG) before and after the pharmaceutical intervention? Does the distribution of resolved and unresolved DRPs depend on group allocation (IG vs. CG)? What is the mean number of consented, unresolved DRPs of high relevance at hospital discharge? How does the mean number of consented, unresolved DRPs per relevance category change within the IG and CG before and after the intervention? How does the mean number of consented, unresolved DRPs of high relevance change within the IG and CG from admission to discharge? | — |
Countries
Germany
Contacts
Public ContactChristian Heise
Apotheke der Universitätsmedizin Mainz
Outcome results
None listed